001     154249
005     20240318115418.0
024 7 _ |a pmc:PMC8675410
|2 pmc
024 7 _ |a 10.1002/hbm.25029
|2 doi
024 7 _ |a pmid:32420680
|2 pmid
024 7 _ |a 1065-9471
|2 ISSN
024 7 _ |a 1097-0193
|2 ISSN
024 7 _ |a altmetric:82313238
|2 altmetric
037 _ _ |a DZNE-2021-00110
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Hoogman, Martine
|b 0
245 _ _ |a Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure.
260 _ _ |a New York, NY
|c 2022
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1710757565_18976
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Neuroimaging has been extensively used to study brain structure and function in individuals with attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) over the past decades. Two of the main shortcomings of the neuroimaging literature of these disorders are the small sample sizes employed and the heterogeneity of methods used. In 2013 and 2014, the ENIGMA-ADHD and ENIGMA-ASD working groups were respectively, founded with a common goal to address these limitations. Here, we provide a narrative review of the thus far completed and still ongoing projects of these working groups. Due to an implicitly hierarchical psychiatric diagnostic classification system, the fields of ADHD and ASD have developed largely in isolation, despite the considerable overlap in the occurrence of the disorders. The collaboration between the ENIGMA-ADHD and -ASD working groups seeks to bring the neuroimaging efforts of the two disorders closer together. The outcomes of case-control studies of subcortical and cortical structures showed that subcortical volumes are similarly affected in ASD and ADHD, albeit with small effect sizes. Cortical analyses identified unique differences in each disorder, but also considerable overlap between the two, specifically in cortical thickness. Ongoing work is examining alternative research questions, such as brain laterality, prediction of case-control status, and anatomical heterogeneity. In brief, great strides have been made toward fulfilling the aims of the ENIGMA collaborations, while new ideas and follow-up analyses continue that include more imaging modalities (diffusion MRI and resting-state functional MRI), collaborations with other large databases, and samples with dual diagnoses.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a ADHD
|2 Other
650 _ 7 |a ASD
|2 Other
650 _ 7 |a ENIGMA
|2 Other
650 _ 7 |a cortex
|2 Other
650 _ 7 |a neuroimaging
|2 Other
650 _ 7 |a subcortical volumes
|2 Other
650 _ 2 |a Attention Deficit Disorder with Hyperactivity: diagnostic imaging
|2 MeSH
650 _ 2 |a Attention Deficit Disorder with Hyperactivity: pathology
|2 MeSH
650 _ 2 |a Autism Spectrum Disorder: diagnostic imaging
|2 MeSH
650 _ 2 |a Autism Spectrum Disorder: pathology
|2 MeSH
650 _ 2 |a Brain: diagnostic imaging
|2 MeSH
650 _ 2 |a Brain: pathology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Multicenter Studies as Topic
|2 MeSH
650 _ 2 |a Neuroimaging
|2 MeSH
650 _ 2 |a Neurosciences
|2 MeSH
700 1 _ |a van Rooij, Daan
|b 1
700 1 _ |a Klein, Marieke
|b 2
700 1 _ |a Boedhoe, Premika
|b 3
700 1 _ |a Ilioska, Iva
|b 4
700 1 _ |a Li, Ting
|b 5
700 1 _ |a Patel, Yash
|b 6
700 1 _ |a Postema, Merel C
|b 7
700 1 _ |a Zhang-James, Yanli
|b 8
700 1 _ |a Anagnostou, Evdokia
|b 9
700 1 _ |a Arango, Celso
|b 10
700 1 _ |a Auzias, Guillaume
|b 11
700 1 _ |a Banaschewski, Tobias
|b 12
700 1 _ |a Bau, Claiton H D
|b 13
700 1 _ |a Behrmann, Marlene
|b 14
700 1 _ |a Bellgrove, Mark A
|b 15
700 1 _ |a Brandeis, Daniel
|b 16
700 1 _ |a Brem, Silvia
|b 17
700 1 _ |a Busatto, Geraldo F
|b 18
700 1 _ |a Calderoni, Sara
|b 19
700 1 _ |a Calvo, Rosa
|b 20
700 1 _ |a Castellanos, Francisco X
|b 21
700 1 _ |a Coghill, David
|b 22
700 1 _ |a Conzelmann, Annette
|b 23
700 1 _ |a Daly, Eileen
|b 24
700 1 _ |a Deruelle, Christine
|b 25
700 1 _ |a Dinstein, Ilan
|b 26
700 1 _ |a Durston, Sarah
|b 27
700 1 _ |a Ecker, Christine
|b 28
700 1 _ |a Ehrlich, Stefan
|b 29
700 1 _ |a Epstein, Jeffery N
|b 30
700 1 _ |a Fair, Damien A
|b 31
700 1 _ |a Fitzgerald, Jacqueline
|0 P:(DE-HGF)0
|b 32
700 1 _ |a Freitag, Christine M
|b 33
700 1 _ |a Research, Psychotherapy Autism
|b 34
700 1 _ |a Frodl, Thomas
|0 P:(DE-2719)2812075
|b 35
|u dzne
700 1 _ |a Gallagher, Louise
|b 36
700 1 _ |a Grevet, Eugenio H
|b 37
700 1 _ |a Haavik, Jan
|b 38
700 1 _ |a Hoekstra, Pieter J
|b 39
700 1 _ |a Janssen, Joost
|b 40
700 1 _ |a Karkashadze, Georgii
|b 41
700 1 _ |a King, Joseph A
|b 42
700 1 _ |a Konrad, Kerstin
|b 43
700 1 _ |a Kuntsi, Jonna
|b 44
700 1 _ |a Lazaro, Luisa
|b 45
700 1 _ |a Lerch, Jason P
|b 46
700 1 _ |a Lesch, Klaus-Peter
|b 47
700 1 _ |a Louza, Mario R
|b 48
700 1 _ |a Luna, Beatriz
|b 49
700 1 _ |a Mattos, Paulo
|b 50
700 1 _ |a McGrath, Jane
|b 51
700 1 _ |a Muratori, Filippo
|b 52
700 1 _ |a Murphy, Clodagh
|b 53
700 1 _ |a Nigg, Joel T
|b 54
700 1 _ |a Oberwelland-Weiss, Eileen
|b 55
700 1 _ |a O'Gorman Tuura, Ruth L
|b 56
700 1 _ |a O'Hearn, Kirsten
|b 57
700 1 _ |a Oosterlaan, Jaap
|b 58
700 1 _ |a Parellada, Mara
|b 59
700 1 _ |a Pauli, Paul
|b 60
700 1 _ |a Plessen, Kerstin J
|b 61
700 1 _ |a Ramos-Quiroga, J Antoni
|b 62
700 1 _ |a Reif, Andreas
|b 63
700 1 _ |a Reneman, Liesbeth
|0 P:(DE-HGF)0
|b 64
700 1 _ |a Retico, Alessandra
|0 P:(DE-HGF)0
|b 65
700 1 _ |a Rosa, Pedro G P
|b 66
700 1 _ |a Rubia, Katya
|b 67
700 1 _ |a Shaw, Philip
|b 68
700 1 _ |a Silk, Tim J
|b 69
700 1 _ |a Tamm, Leanne
|b 70
700 1 _ |a Vilarroya, Oscar
|b 71
700 1 _ |a Walitza, Susanne
|b 72
700 1 _ |a Jahanshad, Neda
|b 73
700 1 _ |a Faraone, Stephen V
|b 74
700 1 _ |a Neuroscience, of
|b 75
700 1 _ |a Francks, Clyde
|0 P:(DE-HGF)0
|b 76
700 1 _ |a van den Heuvel, Odile A
|0 P:(DE-HGF)0
|b 77
700 1 _ |a Paus, Tomas
|b 78
700 1 _ |a Thompson, Paul M
|b 79
700 1 _ |a Buitelaar, Jan K
|b 80
700 1 _ |a Franke, Barbara
|0 P:(DE-HGF)0
|b 81
|e Corresponding author
773 _ _ |a 10.1002/hbm.25029
|g p. hbm.25029
|0 PERI:(DE-600)1492703-2
|n 1
|p 37-55
|t Human brain mapping
|v 43
|y 2022
|x 1097-0193
856 4 _ |u https://pub.dzne.de/record/154249/files/Hoogman_et_al_2020_Consortium_neuroscience_of_attention_deficit_hyperactivity.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/154249/files/Hoogman_et_al_2020_Consortium_neuroscience_of_attention_deficit_hyperactivity.gif?subformat=icon
|x icon
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/154249/files/Hoogman_et_al_2020_Consortium_neuroscience_of_attention_deficit_hyperactivity.jpg?subformat=icon-1440
|x icon-1440
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/154249/files/Hoogman_et_al_2020_Consortium_neuroscience_of_attention_deficit_hyperactivity.jpg?subformat=icon-180
|x icon-180
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/154249/files/Hoogman_et_al_2020_Consortium_neuroscience_of_attention_deficit_hyperactivity.jpg?subformat=icon-640
|x icon-640
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/154249/files/Hoogman_et_al_2020_Consortium_neuroscience_of_attention_deficit_hyperactivity.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:154249
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 35
|6 P:(DE-2719)2812075
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 2 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-27
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2021-01-27
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-27
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-27
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-22
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2022-09-27T20:46:01Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2022-09-27T20:46:01Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2022-09-27T20:46:01Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-22
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b HUM BRAIN MAPP : 2021
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-22
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-22
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b HUM BRAIN MAPP : 2021
|d 2022-11-22
920 1 _ |0 I:(DE-2719)5000006
|k AG Düzel
|l Clinical Neurophysiology and Memory
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000006
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21